Skip to main content

Zhou Rong's Form 4 filing

Amphastar Pharmaceuticals, Inc. (AMPH) · filed Dec 16, 2024

Accession no.
0001415889-24-029491
Filed
Dec 16, 2024
Trade date
Dec 12-13, 2024
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $672.9K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Zhou RongCIK 0001645326Officer (SENIOR EVP, PRODUCTION CENTER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 12, 2024Common StockMOption exerciseAcquired+7,000$11.33+$79,310125,469Direct
Dec 12, 2024Common StockSSaleDisposed−7,000$44.43−$311,010118,469Direct
Dec 13, 2024Common StockMOption exerciseAcquired+8,000$11.33+$90,640126,469Direct
Dec 13, 2024Common StockSSaleDisposed−8,000$45.23−$361,840118,469Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 12, 2024Common StockMOption exerciseDisposed−7,000$0.00$017,787Direct
Dec 13, 2024Common StockMOption exerciseDisposed−8,000$0.00$09,787Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)